 Analysts forecast that Mersana Therapeutics Inc NASDAQ:MRSN will report 430,000.00 in sales for the current quarter, Zacks reports. Two analysts have provided estimates for Mersana Therapeutics earnings. The highest sales estimate is 600,000.00 and the lowest is 250,000.00. Mersana Therapeutics posted sales of 200,000.00 during the same quarter last year, which would indicate a positive ... 